54868-5436 : Pilocarpine Hydrochloride 5 mg Oral Tablet


NDC: 54868-5436
Labeler: Physicians Total Care, Inc.
Product Type: Human Prescription Drug
Drug Name:  Pilocarpine Hydrochloride
Dosage Form: Oral Tablet, Film Coated
Application #: ANDA077220
Rev. Date: 


Appearance:


Markings: LAN;1313
Shapes:  Round
Colors:  White
Size (mm): 6
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

LAN 1313: (0527-1313) Pilocarpine Hydrochloride 5 mg Oral Tablet by Physicians Total Care, Inc.
The above image is provided by the U.S. National Library of Medicine (NLM) and is not part of the official label.

NDC Package Codes:

  • 54868-5436-0: 15 TABLET, FILM COATED IN 1 BOTTLE (54868‑5436‑0)
  • 54868-5436-1: 90 TABLET, FILM COATED IN 1 BOTTLE (54868‑5436‑1)
  • 54868-5436-2: 100 TABLET, FILM COATED IN 1 BOTTLE (54868‑5436‑2)

Active Ingredients:

  • Pilocarpine Hydrochloride

Dosage Strength:

  • 5 mg

Inactive Ingredients:

  • Cellulose, Microcrystalline
  • Stearic Acid
  • Polyvinyl Alcohol
  • Titanium Dioxide
  • Polyethylene Glycol
  • Talc

Pharmaceutical Classes:

  • Cholinergic Agonists [MoA]
  • Cholinergic Muscarinic Agonists [MoA]
  • Cholinergic Receptor Agonist [EPC]

Related Products:

Based on records with the same trade name.
  • 0054-0056 Pilocarpine Hydrochloride 5 mg Oral Tablet by Roxane Laboratories, Inc
  • 0115-5911 Pilocarpine Hydrochloride 7.5 mg Oral Tablet by Global Pharmaceuticals, Division of Impax Laboratories, Inc.
  • 0115-5922 Pilocarpine Hydrochloride 5 mg Oral Tablet by Global Pharmaceuticals, Division of Impax Laboratories, Inc.
  • 0179-0153 Pilocarpine Hydrochloride 5 mg Oral Tablet, Film Coated by Kaiser Foundation Hospitals
  • 0228-2801 Pilocarpine Hydrochloride 5 mg Oral Tablet by Actavis Elizabeth LLC
  • 0228-2837 Pilocarpine Hydrochloride 7.5 mg Oral Tablet by Actavis Elizabeth LLC
  • 0527-1313 Pilocarpine Hydrochloride 5 mg Oral Tablet by Lannett Company, Inc.
  • 0527-1407 Pilocarpine Hydrochloride 7.5 mg Oral Tablet by Lannett Company, Inc.
  • 10135-589 Pilocarpine Hydrochloride 5 mg Oral Tablet, Film Coated by Marlex Pharmaceuticals Inc
  • 10135-590 Pilocarpine Hydrochloride 7.5 mg Oral Tablet, Film Coated by Marlex Pharmaceuticals Inc
  • 10135-680 Pilocarpine Hydrochloride 5 mg Oral Tablet, Film Coated by Marlex Pharmaceuticals Inc
  • 16714-121 Pilocarpine Hydrochloride 5 mg Oral Tablet, Film Coated by Northstar Rx LLC
  • 16714-122 Pilocarpine Hydrochloride 7.5 mg Oral Tablet, Film Coated by Northstar Rx LLC
  • 17478-223 Pilocarpine Hydrochloride 10 mg/ml Ophthalmic Solution/ Drops by Akorn, Inc.
  • 17478-224 Pilocarpine Hydrochloride 20 mg/ml Ophthalmic Solution/ Drops by Akorn, Inc.
  • 17478-226 Pilocarpine Hydrochloride 40 mg/ml Ophthalmic Solution/ Drops by Akorn, Inc.
  • 21695-368 Pilocarpine Hydrochloride 10 mg/ml Conjunctival Solution/ Drops by Rebel Distributors Corp
  • 21695-601 Pilocarpine Hydrochloride 5 mg Oral Tablet by Rebel Distributors Corp
  • 50268-652 Pilocarpine Hydrochloride 5 mg Oral Tablet, Film Coated by Avpak
  • 52125-502 Pilocarpine Hydrochloride 40 mg/1 Ophthalmic Solution by Remedyrepack Inc.
  • More related products ...

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 54868-5436 QR Code

< Prev: 54868-5435Next: 54868-5437 >

Related Discussions:

Image of Pilocarpine
does anyone have any image of this pill white small tablet with 54 on top and 647 on bottom its Pilocarpine 5mg, I'v... 1 reply
pilocarpine
## Hello my name is EUnice Salazar and try to found pilocarpine 5mg,. I live in Los Angeles,. i don*t have any prescript... 1 reply




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.